Immune Monitoring Workshop II Schedule

November 4, 2004
Fairmont Hotel
San Francisco, CA

7:00am-8:00am Continental Breakfast
8:00am-8:30am

8:00am-8:05am

8:05am-8:10am

8:10am-8:30am

Introductory Remarks
(Group Session)

Welcome
Ulrich Keilholz

Workshop Plan
Walter Urba

Challenges of Biologics Development: the FDA/CBER Experience
Steven Hirschfeld

8:30am-10:00am

8:30am-8:45am

8:45am-9:00am

9:00am-9:15am

9:15am-9:30am

9:30am-9:45am

9:45am-10:00am

State of the Field Summaries
(Group Session)

Clinical Trial to Assess Vaccine Characteristics
Jeffrey Weber

Assay Validation for Vaccine Potency Assessment
Nora Disis

Monitoring of Multi-Antigen Vaccines
TBD

Functional Cytometry
Vernon Maino

Migration of Tumor-Specific T Cells
Carmen Scheibenbogen

Tumor Escape Mechanisms: Clinical Observations
TBD

10:00am-10:15am Refreshment Break
10:15am-12:30am Parallel Session: Abstract Presentations
(Group Session)

Immune Monitoring of Cancer Treatments
Michael Atkins, Michael Lotze

10:15am-12:30pm Breakout Sessions (Tier I)
Assay Methodology and Validation
(Invitation Only)

Functional Cytometry
Vernon Maino, Ulrich Keilholz

Assay

Validation for Vaccine Potency Assessment
TBD, Nora Disis

Montoring of Multi-Antigen Vaccines
Craig Slingluff

10:15am-12:30pm Breakout Sessions (Tier II)
Clinical Trial Methodology and Observations

(Invitation Only)

Clinical Trials to Assess Vaccine Characteristics
Jeffrey Weber, Walter Urba

Migration of Tumor-Specific T Cells
Carmen Scheibenbogen, Patrick Hwu

Tumor Escape Mechanisms: Clinical Observations
Cassian Yee, Pedro Romero

12:30pm-1:30pm Lunch
1:30pm-2:00pm Group Lecture: Genomics and Proteomics in Immunotherapy Trials
Francesco Marincola
2:00pm-3:00pm Reporting Session/ Panel Discussion (Tier I)
(Group Session)

Functional Cytometry
Vernon Maino, Ulrich Keilholz

Assay Validation for Vaccine Potency Assessment
TBD, Nora Disis

Montoring of Multi-Antigen Vaccines
Craig Slingluff

3:00pm-3:30pm Refreshment Break
3:30pm-4:30pm Reporting Session/ Panel Discussion (Tier II)
(Group Session)

Clinical Trials to Assess Vaccine Characteristics
Jeffrey Weber, Walter Urba

Migration of Tumor-Specific T Cells
Carmen Scheibenbogen, Patrick Hwu

Tumor Escape Mechanisms: Clinical Observations
Cassian Yee, Pedro Romero

4:30pm-5:00pm General Discussion: Consensus and Consequences
(Group Session)
5:00pm  Farewell and Future Plans